[EN] INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE [FR] INHIBITEURS DE L'INDOLÉAMINE 2,3-DIOXYGÉNASE ET LEURS PROCÉDÉS D'UTILISATION
Copper-Mediated Oxidative Fluorination of Aryl Stannanes with Fluoride
作者:Raymond F. Gamache、Christopher Waldmann、Jennifer M. Murphy
DOI:10.1021/acs.orglett.6b02125
日期:2016.9.16
A regiospecific method for the oxidative fluorination of aryl stannanes using tetrabutylammonium triphenyldifluorosilicate (TBAT) and copper(II) triflate is described. This reaction is robust, uses readily available reagents, and proceeds via a stepwise protocol under mild conditions (60 °C, 3.2 h). Broad functional group tolerance, including arenes containing protic and nucleophilic groups, is demonstrated
N-alkyl(cycloalkyl)benzylamines, p-fluorobenzylamines, (1-phenylethyl)amines, [1-(p-fluorophenyl)ethyl]amines were synthesized by hydroamination of aldehydes and ketones with oximes.
Optimization of CRF1R binding affinity of 2-(2,4,6-trichlorophenyl)-4-trifluoromethyl-5-aminomethylthiazoles through rapid and selective parallel synthesis
作者:Dmitry Zuev、Jodi A. Michne、Sokhom S. Pin、Jie Zhang、Matthew T. Taber、Gene M. Dubowchik
DOI:10.1016/j.bmcl.2004.10.055
日期:2005.1
An efficient approach was developed to synthesize 2-(2,4,6-trichlorophenylamino)-4-trifluoromethyl-5-aminomethylthiazoles, corticotropin-releasing factor type 1 receptor (CRF1R) antagonists, by monoalkylation of amines with chloromethyl intermediate 5. The effect of variations in aminomethyl side chain of 6 on binding affinity is discussed. (C) 2004 Elsevier Ltd. All rights reserved.
Oxyguanidines. Part 2: Discovery of a novel orally active thrombin inhibitor through structure-based drug design and parallel synthesis
作者:Tianbao Lu、Thomas Markotan、Frank Coppo、Bruce Tomczuk、Carl Crysler、Stephen Eisennagel、John Spurlino、Lisa Gremminger、Richard M Soll、Edward C Giardino、Roger Bone
DOI:10.1016/j.bmcl.2004.05.002
日期:2004.7
Through structure-based drug design and parallel synthesis, we have discovered a novel series of nonpeptidic phenyl-based thrombin inhibitors using oxyguanidines as guanidine bioisosteres. These compounds have been found to be highly potent, highly selective, and orally bioavailable. (C) 2004 Elsevier Ltd. All rights reserved.
Srivastav, Maneesh Kumar; Rajeeva; Salahuddin, Md., Indian Journal of Heterocyclic Chemistry, 2014, vol. 24, # 2, p. 115 - 118